Ontology highlight
ABSTRACT:
SUBMITTER: Munsel EJ
PROVIDER: S-EPMC7671021 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Munsel Erin J EJ Bryan Peter J PJ Binstadt Bryce A BA Bullock Danielle D Correll Colleen K CK Downs Elissa M EM Hobday Patricia M PM Larson-Nath Catherine C Sudel Boris B Vehe Richard K RK
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20201113 8
<h4>Objectives</h4>To compare infusion reaction rates between rapid infliximab (REMICADE, Janssen Biotech Inc) infusions and previous standard 2- to 3-hour infusions; additionally, to assess patient satisfaction and reduction in chair time associated with rapid infliximab infusions.<h4>Methods</h4>Pediatric rheumatology and gastroenterology patients receiving maintenance infliximab therapy using a standard 2- to 3-hour titrated infusion had the opportunity to enroll in the non-titrated rapid 1-h ...[more]